These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 2679824

  • 1. [Immunohistochemical study of c-myc oncogene product in human brain tumors].
    Nakajima Y, Yoshimine T, Hayakawa T, Maruno M, Mushiroi T, Nakagawa H, Mogami H.
    No To Shinkei; 1989 Jun; 41(6):617-21. PubMed ID: 2679824
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A, Riva P, Lindstedt R, Davidoff MS, Mehraein P, Weis S.
    Cancer; 2003 Dec 01; 98(11):2430-9. PubMed ID: 14635078
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
    Krajewski S, Chatten J, Hanada M, Reed JC.
    Lab Invest; 1995 Jan 01; 72(1):42-54. PubMed ID: 7837790
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B, Bodey B, Siegel SE, Kaiser HE.
    In Vivo; 1999 Jan 01; 13(4):357-73. PubMed ID: 10586378
    [Abstract] [Full Text] [Related]

  • 13. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
    Yamamoto M, Fukushima T, Hayashi S, Ikeda K, Tsugu H, Kimura H, Soma G, Tomonaga M.
    Anticancer Res; 2000 Jan 01; 20(1C):611-8. PubMed ID: 10769704
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Cell proliferation and glial fibrillary acidic protein in brain tumors].
    Kunz J, Gottschalk J, Jänisch W, Schulz W.
    Acta Histochem; 1986 Jan 01; 80(1):53-61. PubMed ID: 3099535
    [Abstract] [Full Text] [Related]

  • 18. [Glial fibrillary acidic protein and central nervous system tumors. Immunohistochemical study of a series of 207 cases. 2: Medulloblastomas. Hemangioblastomas. Other tumors. Discussion].
    Pasquier B, Lachard A, Pasquier D, Couderc P, Delpech B, Courel MN.
    Ann Pathol; 1983 Sep 01; 3(3):203-11. PubMed ID: 6354202
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system.
    Reubi JC, Lang W, Maurer R, Koper JW, Lamberts SW.
    Cancer Res; 1987 Nov 01; 47(21):5758-64. PubMed ID: 2889527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.